semaglutide for type 2 diabetes Maximizing Semaglutide: Understanding the Doses & Weight Loss Novo Nordisk to Seek Approval
Description
The FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) are formulated as the pure active ingredient with minimal additives
A recent study developed a new dual agonist combination of semaglutide and MK-801 (an NMDA antagonist-based antidepressant) to mitigate the known yo-yo effect of GLP-1RA [51]

Clinical considerations: Formulation matters

Comparative effectiveness of bariatric surgery versus GLP-1 receptor agonists in reducing the risk of new-onset of NASH: a retrospective multinational cohort study from North America and Europe

Weight loss, however, may be slightly slower compared to non-diabetic populations, likely due to the metabolic resistance created by chronic insulin dysregulation and the weight gain effects of concurrent diabetes medications like sulfonylureas or insulin

Those are the real drivers, Carroll, also not involved in this study, explained
